|
BJS has released Methamphetamine, Cocaine, and Other Psychostimulant Offenses in Federal Courts, 2022. This report uses data from BJS’s Federal Justice Statistics Program (FJSP) and other published sources to present statistics on persons arrested and convicted for a federal drug offense involving methamphetamine, cocaine, methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), and other amphetamines. It focuses on psychostimulants, including their classification under the Controlled Substances Act (P.L. 91–513), persons arrested for a federal offense involving psychostimulants, deaths due to overdose, and persons sentenced for a federal offense involving these substances.
The FJSP receives administrative data files from six federal criminal justice agencies: the U.S. Marshals Service, Drug Enforcement Administration, Executive Office for U.S. Attorneys, Administrative Office of the U.S. Courts, U.S. Sentencing Commission, and Federal Bureau of Prisons. Data represent the federal criminal case-processing stages from arrest to imprisonment and release. FJSP data are available in the Federal Criminal Case Processing Statistics Data Tool, which provides statistics by stage of the federal criminal case process, including law enforcement, prosecution and courts, and incarceration.
Methamphetamine, Cocaine, and Other Psychostimulant Offenses in Federal Courts, 2022 (NCJ 309288) was written by BJS Statistician Mark Motivans, PhD. The report, related documents, and additional information about BJS’s statistical publications and programs are available on the BJS website at bjs.ojp.gov.
The Bureau of Justice Statistics of the U.S. Department of Justice is the principal federal agency responsible for collecting, analyzing, and disseminating reliable statistics on crime and criminal justice in the United States. Kevin M. Scott, PhD, is the acting director.
|
